Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A response to "Personalised medicine and population health: breast and ovarian cancer".

Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E.

Hum Genet. 2019 Mar;138(3):287-289. doi: 10.1007/s00439-019-01984-z. Epub 2019 Feb 27. No abstract available.

2.

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, de Villiers CB, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, Easton DF, Antoniou AC.

Genet Med. 2019 Jun;21(6):1462. doi: 10.1038/s41436-019-0459-4.

PMID:
30787466
3.

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, Babb de Villiers C, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, Easton DF, Antoniou AC.

Genet Med. 2019 Jan 15. doi: 10.1038/s41436-018-0406-9. [Epub ahead of print] Erratum in: Genet Med. 2019 Feb 21;:.

PMID:
30643217
4.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Bremer M, Brenner H, Brentnall A, Brock IW, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Campa D, Carter BD, Castelao JE, Chanock SJ, Chlebowski R, Christiansen H, Clarke CL, Collée JM, Cordina-Duverger E, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fletcher O, Flyger H, Försti A, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Gilyazova IR, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hankinson SE, Harkness EF, Hart SN, He W, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Jakimovska M, Jakubowska A, Janni W, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kaczmarek K, Kataja V, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Knight JA, Ko YD, Kosma VM, Koutros S, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Lilyquist J, Lindblom A, Lindström S, Lissowska J, Lo WY, Loibl S, Long J, Lubiński J, Lux MP, MacInnis RJ, Maishman T, Makalic E, Maleva Kostovska I, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Martinez ME, Mavroudis D, McLean C, Meindl A, Menon U, Middha P, Miller N, Moreno F, Mulligan AM, Mulot C, Muñoz-Garzon VM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, Offit K, Olson JE, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Peto J, Pinchev M, Plaseska-Karanfilska D, Polley EC, Prentice R, Presneau N, Prokofyeva D, Purrington K, Pylkäs K, Rack B, Radice P, Rau-Murthy R, Rennert G, Rennert HS, Rhenius V, Robson M, Romero A, Ruddy KJ, Ruebner M, Saloustros E, Sandler DP, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Schwentner L, Scott C, Scott RJ, Seynaeve C, Shah M, Sherman ME, Shrubsole MJ, Shu XO, Slager S, Smeets A, Sohn C, Soucy P, Southey MC, Spinelli JJ, Stegmaier C, Stone J, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Truong T, Tzardi M, Ulmer HU, Untch M, Vachon CM, van Veen EM, Vijai J, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zhang Y, Zheng W, Ziogas A; ABCTB Investigators; kConFab/AOCS Investigators; NBCS Collaborators, Dunning AM, Thompson DJ, Chenevix-Trench G, Chang-Claude J, Schmidt MK, Hall P, Milne RL, Pharoah PDP, Antoniou AC, Chatterjee N, Kraft P, García-Closas M, Simard J, Easton DF.

Am J Hum Genet. 2019 Jan 3;104(1):21-34. doi: 10.1016/j.ajhg.2018.11.002. Epub 2018 Dec 13.

5.

Perceptions of self-rated health among stroke survivors: a qualitative study in the United Kingdom.

Mavaddat N, Sadler E, Lim L, Williams K, Warburton E, Kinmonth AL, Mant J, Burt J, McKevitt C.

BMC Geriatr. 2018 Apr 2;18(1):81. doi: 10.1186/s12877-018-0765-8.

6.

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, Dennis J, Wilcox AN, Hopper JL, Southey MC, Keeman R, Fasching PA, Beckmann MW, Gago-Dominguez M, Castelao JE, Guénel P, Truong T, Bojesen SE, Flyger H, Brenner H, Arndt V, Brauch H, Brüning T, Mannermaa A, Kosma VM, Lambrechts D, Keupers M, Couch FJ, Vachon C, Giles GG, MacInnis RJ, Figueroa J, Brinton L, Czene K, Brand JS, Gabrielson M, Humphreys K, Cox A, Cross SS, Dunning AM, Orr N, Swerdlow A, Hall P, Pharoah PDP, Schmidt MK, Easton DF, Chatterjee N, Chang-Claude J, García-Closas M.

Int J Epidemiol. 2018 Apr 1;47(2):526-536. doi: 10.1093/ije/dyx242.

7.

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.

Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J, Domchek SM, Robson M, Spurdle AB, Ramus SJ, Mavaddat N, Terry MB, Neuhausen SL, Schmutzler RK, Simard J, Pharoah PDP, Offit K, Couch FJ, Chenevix-Trench G, Easton DF, Antoniou AC.

J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw302.

8.
9.

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.

Muranen TA, Mavaddat N, Khan S, Fagerholm R, Pelttari L, Lee A, Aittomäki K, Blomqvist C, Easton DF, Nevanlinna H.

Breast Cancer Res Treat. 2016 Aug;158(3):463-9. doi: 10.1007/s10549-016-3897-6. Epub 2016 Jul 20.

10.

Post-sanctions era in Iran: opportunity for science and publication.

Adab P, Mavaddat N, Lee C, Foroughi M, Lilford RJ.

Lancet. 2016 Jul 2;388(10039):28-9. doi: 10.1016/S0140-6736(16)30897-2. No abstract available.

PMID:
27397788
11.

Relationship of Self-Rated Health to Stroke Incidence and Mortality in Older Individuals with and without a History of Stroke: A Longitudinal Study of the MRC Cognitive Function and Ageing (CFAS) Population.

Mavaddat N, van der Linde R, Parker R, Savva G, Kinmonth AL, Brayne C, Mant J.

PLoS One. 2016 Feb 29;11(2):e0150178. doi: 10.1371/journal.pone.0150178. eCollection 2016.

12.

Prediction of breast cancer risk based on profiling with common genetic variants.

Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M.

J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv036. doi: 10.1093/jnci/djv036. Print 2015 May.

13.

Association of self-rated health with multimorbidity, chronic disease and psychosocial factors in a large middle-aged and older cohort from general practice: a cross-sectional study.

Mavaddat N, Valderas JM, van der Linde R, Khaw KT, Kinmonth AL.

BMC Fam Pract. 2014 Nov 25;15:185. doi: 10.1186/s12875-014-0185-6.

14.

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Mavaddat N, Roalfe A, Fletcher K, Lip GY, Hobbs FD, Fitzmaurice D, Mant J.

Stroke. 2014 Sep;45(9):e192. doi: 10.1161/STROKEAHA.114.006301. Epub 2014 Aug 5. No abstract available.

PMID:
25096732
15.

Relationship of self-rated health with fatal and non-fatal outcomes in cardiovascular disease: a systematic review and meta-analysis.

Mavaddat N, Parker RA, Sanderson S, Mant J, Kinmonth AL.

PLoS One. 2014 Jul 30;9(7):e103509. doi: 10.1371/journal.pone.0103509. eCollection 2014. Review.

16.

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).

Mavaddat N, Roalfe A, Fletcher K, Lip GY, Hobbs FD, Fitzmaurice D, Mant J.

Stroke. 2014 May;45(5):1381-6. doi: 10.1161/STROKEAHA.113.004009. Epub 2014 Apr 1.

17.

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.

Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC; Consortium of Investigators of Modifiers of BRCA1/2; Breast Cancer Association Consortium.

Br J Cancer. 2014 Jan 21;110(2):535-45. doi: 10.1038/bjc.2013.730. Epub 2013 Dec 17.

18.
19.

Transient neurological symptoms in the older population: report of a prospective cohort study--the Medical Research Council Cognitive Function and Ageing Study (CFAS).

Mavaddat N, Savva GM, Lasserson DS, Giles MF, Brayne C, Mant J.

BMJ Open. 2013 Jul 24;3(7). pii: e003195. doi: 10.1136/bmjopen-2013-003195. Print 2013.

20.

Self-rated health and cardiovascular disease incidence: results from a longitudinal population-based cohort in Norfolk, UK.

van der Linde RM, Mavaddat N, Luben R, Brayne C, Simmons RK, Khaw KT, Kinmonth AL.

PLoS One. 2013 Jun 3;8(6):e65290. doi: 10.1371/journal.pone.0065290. Print 2013.

21.

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF; EMBRACE.

J Natl Cancer Inst. 2013 Jun 5;105(11):812-22. doi: 10.1093/jnci/djt095. Epub 2013 Apr 29.

PMID:
23628597
22.

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.

Fischer C, Kuchenbäcker K, Engel C, Zachariae S, Rhiem K, Meindl A, Rahner N, Dikow N, Plendl H, Debatin I, Grimm T, Gadzicki D, Flöttmann R, Horvath J, Schröck E, Stock F, Schäfer D, Schwaab I, Kartsonaki C, Mavaddat N, Schlegelberger B, Antoniou AC, Schmutzler R; German Consortium for Hereditary Breast and Ovarian Cancer.

J Med Genet. 2013 Jun;50(6):360-7. doi: 10.1136/jmedgenet-2012-101415. Epub 2013 Apr 6.

PMID:
23564750
23.

Varying uses of the ABCD2 scoring system in primary and secondary care: a qualitative study.

Edwards D, Cohn SR, Mavaddat N, Virdee SK, Lasserson D, Milner S, Giles M, McManus R, Mant J.

BMJ Open. 2012 Nov 28;2(6). pii: e001501. doi: 10.1136/bmjopen-2012-001501. Print 2012.

24.

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB; HEBON, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C; EMBRACE, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L; GEMO Study Collaborators, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S; kConFab Investigators, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K; SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC; Consortium of Investigators of Modifiers of BRCA1/2.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47. doi: 10.1158/1055-9965.EPI-11-0775. Epub 2011 Dec 5.

25.

Primary care experience of people with long-standing psychological problems: evidence from a national survey in England.

Abel G, Mavaddat N, Elliott M, Lyratzopoulos Y, Roland M.

Int Rev Psychiatry. 2011;23(1):2-9. doi: 10.3109/09540261.2010.545985.

PMID:
21338292
26.

Primary care research and clinical practice: cardiovascular disease.

Mavaddat N, Mant J.

Postgrad Med J. 2010 Dec;86(1022):696-703. doi: 10.1136/pgmj.2009.094771. Epub 2010 Nov 1. Review.

PMID:
21041795
27.

What determines Self-Rated Health (SRH)? A cross-sectional study of SF-36 health domains in the EPIC-Norfolk cohort.

Mavaddat N, Kinmonth AL, Sanderson S, Surtees P, Bingham S, Khaw KT.

J Epidemiol Community Health. 2011 Sep;65(9):800-6. doi: 10.1136/jech.2009.090845. Epub 2010 Jun 15.

PMID:
20551149
28.

Genetic susceptibility to breast cancer.

Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M.

Mol Oncol. 2010 Jun;4(3):174-91. doi: 10.1016/j.molonc.2010.04.011. Epub 2010 May 21. Review.

29.

Incorporating tumour pathology information into breast cancer risk prediction algorithms.

Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC.

Breast Cancer Res. 2010;12(3):R28. doi: 10.1186/bcr2576. Epub 2010 May 18.

30.

Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.

Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D, Macinnis RJ, Shah M; SEARCH Team, Easton DF, Antoniou AC.

Breast Cancer Res. 2010;12(1):R10. doi: 10.1186/bcr2476. Epub 2010 Feb 10.

31.

Development of a patient experience questionnaire for primary care mental health.

Mavaddat N, Lester HE, Tait L.

Qual Saf Health Care. 2009 Apr;18(2):147-52. doi: 10.1136/qshc.2007.023143.

PMID:
19342531
32.

Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

Mavaddat N, Dunning AM, Ponder BA, Easton DF, Pharoah PD.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):255-9. doi: 10.1158/1055-9965.EPI-08-0704.

33.

CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase.

Pozo D, Valés-Gómez M, Mavaddat N, Williamson SC, Chisholm SE, Reyburn H.

J Immunol. 2006 Feb 15;176(4):2397-406.

34.

Reaction between ellagic acid and an ultimate carcinogen.

Huetz P, Mavaddat N, Mavri J.

J Chem Inf Model. 2005 Nov-Dec;45(6):1564-70.

PMID:
16309255
35.

Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.

Rizzitelli A, Vremec D, Villadangos JA, Mavaddat N, Wright MD, Shortman K.

Eur J Immunol. 2005 Nov;35(11):3209-20.

36.

Effects of methylphenidate on cognition and apathy in normal pressure hydrocephalus: a case study and review.

Keenan S, Mavaddat N, Iddon J, Pickard JD, Sahakian BJ.

Br J Neurosurg. 2005 Feb;19(1):46-50.

PMID:
16147583
37.

The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D.

Love CA, Harlos K, Mavaddat N, Davis SJ, Stuart DI, Jones EY, Esnouf RM.

Nat Struct Biol. 2003 Oct;10(10):843-8. Epub 2003 Sep 7.

PMID:
12958590
38.

Human thymus contains 2 distinct dendritic cell populations.

Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, Shortman K.

Blood. 2001 Mar 15;97(6):1733-41.

39.

Deficits in decision-making in patients with aneurysms of the anterior communicating artery.

Mavaddat N, Kirkpatrick PJ, Rogers RD, Sahakian BJ.

Brain. 2000 Oct;123 ( Pt 10):2109-17.

PMID:
11004127
40.

Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity.

Mavaddat N, Mason DW, Atkinson PD, Evans EJ, Gilbert RJ, Stuart DI, Fennelly JA, Barclay AN, Davis SJ, Brown MH.

J Biol Chem. 2000 Sep 8;275(36):28100-9.

41.

Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.

Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW.

J Neurosci. 2000 Mar 15;20(6):RC65.

42.

Cognition following subarachnoid hemorrhage from anterior communicating artery aneurysm: relation to timing of surgery.

Mavaddat N, Sahakian BJ, Hutchinson PJ, Kirkpatrick PJ.

J Neurosurg. 1999 Sep;91(3):402-7.

PMID:
10470814
43.
44.

The nature of major histocompatibility complex recognition by gamma delta T cells.

Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, Matis L, Draper RK, Chien YH.

Cell. 1994 Jan 14;76(1):29-37.

PMID:
8287478
45.

An analysis of the relationship between gamma delta T cell receptor V gene usage and non-major histocompatibility complex-restricted cytotoxicity.

Mavaddat N, Robinson BW, Rose AH, Manning LS, Garlepp MJ.

Immunol Cell Biol. 1993 Feb;71 ( Pt 1):27-37.

PMID:
8436409
46.

A clonal analysis of lung T cells derived by bronchoalveolar lavage of healthy individuals.

Garlepp MJ, Rose AH, Bowman RV, Mavaddat N, Dench J, Holt BJ, Baron-Hay M, Holt PG, Robinson BW.

Immunology. 1992 Sep;77(1):31-7.

Supplemental Content

Loading ...
Support Center